EPA/DHA 1:1 | EPA/DHA 2:1 | EPA/DHA 1:2 | Soybean oil | Linseed oil | ||||
---|---|---|---|---|---|---|---|---|
Biomarkers | Mean ± SD | Mean ± SD | Mean ± SD | p | Mean ± SD | P | Mean ± SD | p |
CV RISK FACTORS | ||||||||
Lipid profile | ||||||||
TG (mg/dL) | 86.3 ± 65.1 | 124.5 ± 102.2 | 83.1 ± 10.4 | 108.5 ± 51.9 | 73.5 ± 25.2 | |||
CHOL (mg/dL) | 93.3 ± 26.5 | 98.0 ± 14.8 | 112.3 ± 20.8 | 125.8 ± 16.5 | 118.5 ± 13.5 | |||
LDLc (mg/dL) | 7.64 ± 3.3 | 7.4 ± 0.8 | 8.30 ± 1.3 | 10.39 ± 2.2 | 7.4 ± 1.6 | |||
HDLc (mg/dL) | 37.4 ± 11.1 | 50.4 ± 25.9 | 47.3 ± 8.1 | 51.3 ± 7.8 | 46.8 ± 5.5 | |||
LDLc/HDLc | 0.19 ± 0.5 | 0.20 ± 0.01 | 0.17 ± 0.01 | 0.20 ± 0.2 | 0.19 ± 0.1 | |||
ApoA1 (mg/mL) | 43.0 ± 11.4 | 51.7 ± 11.9 | 47.9 ± 13.8 | 51.4 ± 13.3 | 30.6 ± 2.1 | |||
ApoB100 (mg/mL) | 116.5 ± 16.8 | 137.0 ± 6.4 | 139.4 ± 23.8 | 126.8 ± 13.9 | 152.7 ± 35.7 | |||
ApoB100/ApoA1 | 2.79 ± 0.51 | 2.75 ± 0.54 | 3.10 ± 1.01 | 2.67 ± 1.11 | 5.02 ± 1.29 | a0.029 | ||
b0.019 | ||||||||
d0.029 | ||||||||
Glycaemia | ||||||||
Glucose increase (mmol/L) | -0.75 ± 0.42 | -0.15 ± 0.34 | 0.27 ± 0.49 | a0.001 | 0.53 ± 0.25 | a < 0.001 | - 0.20 ± 0.31 | d0.032 |
Glycated Haemoglobin (%) | 4.14 ± 0.24 | 4.43 ± 0.72 | 4.17 ± 0.30 | 6.39 ± 0.99 | a0.003 | 6.34 ± 1.84 | a0.025 | |
b0.007 | b0.05 | |||||||
c0.004 | c0.032 | |||||||
Insulin increase (ng/mL) | 1.40 ± 0.8 | 0.15 ± 1.90 | 0.42 ± 0.4 | 0.9 ± 1.5 | 0.41 ± 0.5 | |||
Homa index | 7.0 ± 3.0 | 4.1 ± 1.8 | 3.8 ± 1.5 | 6.9 ± 3.8 | 2.9 ± 1.1 | a0.004 | ||
d0.032 |